Even as decentralized clinical trials become more prevalent, the vexing issue of retaining participants throughout the course of a trial will continue to be problematic without a thoughtful approach to keep them engaged.
Institutional review boards are often seen as a barrier to paying participants in clinical research, but thinking on this topic has evolved significantly during the past few years.
Despite the huge advances we have witnessed in recent years, one of the biggest barriers to technology-driven decentralized clinical trial adoption remains a lack of agreed standards for compliance and ethics.
There is ample opportunity for those who can overcome staffing issues and employee burnout to take advantage of the countless new studies waiting for clinical research sites that are adequately prepared to handle them.
Efforts to improve the regulatory review process through standardization, harmonization, and digitalization have gathered steam in recent years with regulators and industry alike pushing forward with data-driven initiatives.